BFF: BE FAST vs. FAST: A Study in the General Public.

Sponsor

Aurora Health Care (Other)

Overall Status

Completed

CT.gov ID

NCT06152016

Collaborator

BayCare Health System (Other), Aurora BayCare Medical Center (Other)

174

Enrollment

Location

Arms

19.1

Actual Duration (Months)

9.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A randomized, blinded prospective study assessing retention of two stroke mnemonics (BE FAST and FAST) in the general public after receiving brief stroke education. Participants were randomized to one of two education arms and retention was tested at 3 different time intervals.

Condition or Disease	Intervention/Treatment	Phase
Stroke	Other: BE-FAST Other: FAST	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

174 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Triple (Participant, Investigator, Outcomes Assessor)

Primary Purpose:

Other

Official Title:

BE FAST vs. FAST: A Randomized Trial Comparing Retention of Stroke Symptoms Between Two Mnemonics in the General Public.

Actual Study Start Date :

Nov 20, 2021

Actual Primary Completion Date :

May 18, 2023

Actual Study Completion Date :

Jun 23, 2023

Arms and Interventions

Arm	Intervention/Treatment
Other: BE-FAST	Other: BE-FAST This intervention includes those randomized to the education with the BE-FAST mnemonic.
Other: FAST	Other: FAST This intervention includes those randomized to the education with the FAST mnemonic.

Arm

Intervention/Treatment

Other: BE-FAST

Other: BE-FAST

This intervention includes those randomized to the education with the BE-FAST mnemonic.

Other: FAST

Other: FAST

This intervention includes those randomized to the education with the FAST mnemonic.

Outcome Measures

Primary Outcome Measures

Recall Visit 1 [60 minutes]
Number/percentage of participants in the FAST and BE-FAST groups at Visit 1 who accurately recall the mnemonic they were taught during the education session.

Secondary Outcome Measures

Retention Rate Symptom [30 days]
Retention rate of each stroke symptom in the mnemonic
Recall Rate Symptom [30 days]
Total number of stroke symptoms that were accurately recalled by the participants
Recall Participant Percentage [30 days]
Number/percentage of participants able to recall all the symptoms included in the mnemonic
Patrial Recall Participant Percentage [30 days]
Number/percentage of participants able to recall 2 or more symptoms of the FAST mnemonic or 3 or more of the BE-FAST mnemonic.
Common Recall Participant Percentage [30 days]
Number/percentage of participants able to recall the more common symptoms of each mnemonic (Facial weakness, arm weakness and speech difficulties)
Retention per Professional Background [30 days]
Compare participants with medical vs. non-medical professional backgrounds and explore whether there are any group differences in retention rates.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Subject 18 years of age or older
Subject speaks English (Does not need interpreter)
Subject able to read English
Subject willing to provide a phone number for future follow up
Subject willing and agreeable to up to 2 phone follow up calls
Subject willing to provide verbal consent to participate

Exclusion Criteria:

Subject non-English speaking (needs interpreter)
Subject has visual or hearing impairment
Subject has history of Dementia or a learning disability
Subject had stroke education within the past year
Subject had a previous stroke

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Aurora BayCare Medical Center	Green Bay	Wisconsin	United States	54311

Sponsors and Collaborators

Aurora Health Care
BayCare Health System
Aurora BayCare Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Ziad Darkhabani, Principal Investigator, Aurora Health Care

ClinicalTrials.gov Identifier:

NCT06152016

Other Study ID Numbers:

19-807

First Posted:

Nov 30, 2023

Last Update Posted:

Nov 30, 2023

Last Verified:

Nov 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Ziad Darkhabani, Principal Investigator, Aurora Health Care

BE-FAST

FAST

Additional relevant MeSH terms:

Stroke

Study Results

No Results Posted as of Nov 30, 2023